156. Immunologic Challenges to HIV Vaccine Design
Session: Symposia: American Association of Immunologists Bridging Immunology and Vaccinology
Friday, October 5, 2007: 12:00 AM
Room: 26AB
.
Juliana McElrath, MD, PhD, FIDSA, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA and  J. McElrath, None.

Juliana McElrath, MD, PhD, is Professor of Medicine at the University fo Washington and a member of the Clinical Research Division of Fred Hutchinson Cancer Research Center. She serves as the Co-director of the FHCRC Vaccine Infectious Disease Institute and Associate Head of the Program in Infectious Diseases. In addition, she is the Principal Investigator and Director of the HIV Vaccine Trials Network Laboratory Program and the FHCRC/UW HIV Vaccine Trials Unit.
Dr. McElrath’s clinical research efforts focus on HIV immunopathogenesis and vaccine development. She has extensive experience with leading and participating in large multidisciplinary studies and international collaborations. Ongoing investigations include understanding mechanisms of controlling HIV in exposed seronegatives, acutely infected patients and long-term nonprogressors. Her laboratory focuses on insights into mucosal immunology as a means to slow HIV transmission.
Dr. McElrath has held a number of national leadership responsibilities, including chairperson and member of the HIV immunology study section (ARR2), co-chair of the NIH PAVE Laboratory Working Group, member of the NIH AIDS Vaccine Research Working Group and the HIV Vaccine Enterprise Laboratory Working Group, and Associate Editor of the Journal of Infectious Diseases. She is a member of the Association of American Physicians and a received a Burroughs-Wellcome Clinical Scientist Translational Award and an NIH Merit Award.



<< Previous Presentation | Next Presentation